Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 221-227

  Speciale, C ^a   Cini, M ^a   Wu, H Q ^b   Salvati, P ^a   Schwarcz, R ^b   Molinari, A ^a   Calabresi, M ^a   Varasi, M ^a  

^a Nerviano Medical Sciences   (Italy)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RODENTIA;

BUTYRIC ACID DERIVATIVE; ENZYME INHIBITOR; FCE 28833; HYDROLASE; KYNURENIC ACID; KYNURENINASE; KYNURENINE 3 MONOOXYGENASE; MIXED FUNCTION OXIDASE; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GERBIL; HIPPOCAMPUS; LIVER; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; TRANSIENT ISCHEMIC ATTACK; WISTAR RAT;

ANIMALS; BRAIN; BUTYRATES; ENZYME INHIBITORS; GERBILLINAE; HIPPOCAMPUS; HYDROLASES; ISCHEMIC ATTACK, TRANSIENT; KYNURENIC ACID; KYNURENINE 3-MONOOXYGENASE; LIVER; MALE; MIXED FUNCTION OXYGENASES; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 0030347302     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_35     Document Type: Article

References (25)

1. Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carlá, V., Pellicciari, R., Mattioli, L., and Moroni, F., 1994, Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neurosci. 61:237.
2. Baran, H., Gramer, M., Hönack, D., and Löscher, W., 1995, Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. Eur. J. Pharmacol., 286:167.
3. Blight, A.R., Cohen, T.I., Saito, K., and Heyes, M.P., 1995, Quinolinic acid accumulation and functional deficits following experimental spinal cord injury, Brain 118:735.
4. Decker, R.H., Brown, R.R., and Price, J.M., 1963, Studies on the biological activity of nicotinylalanine, an analogue of kynurenine, J. Biol. Chem. 238:1049.
5. Heyes, M.P., and Nowak Jr., T.S., 1990, Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil. J. Cereb. Blood Flow Metab. 10:660.
6. Heyes, M.P., Brew, B.J., Martin, A:, Price, R.W., Salazar, A.M., Sidtis, J.J., Yergey, J.A., Mouradian, M.M., Sadler, A.E., Keilp J., Rubinow, D., and Markey, S.P., 1991, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: reationship to clinical and neurologic status. Ann. Neurol. 29:202.
7. McMaster, O.G., Du, F., French, E.D., and Schwarcz, R., (1991) Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: evidence for mediation by NMDA receptors. Exp. Neurol. 113:378.
8. Miller, J.M., MacGarvey, U., and Beal, M.F., 1992, The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations. Neurosci. Lett. 146:115.
9. Nozaki, K., and Beal, M.F., 1992, Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab. 12:400.
10. Okuno, E., Schmidt, W., Parks, D.A., Nakamura, M., and Schwarcz, R., 1991, Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J. Neurochem. 57:533.
11. Parli, C.J., Krieter, P., and Schmidt, B., Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: a potent inhibitor of 3-hydroxyanthranilic acid oxidase. Arch. Biochem. Biophys. 203:161.
12. Pellicciari, R., Natalini, B., Costantino, G., Mahmoud, M.R., Mattioli, L., Sadeghpour, B.M., Moroni, F., Chiarugi, A., and Carpenedo, R., 1994. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem. 37:647.
13. Popovich, P.G., Reinhard Jr., J.F., Flanagan, E.M., and Stokes, B.T., 1994, Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res. 633:348.
14. Reinhard Jr., J.F., Erickson, J.B., and Flanagan, E.M., 1994, Quinolinic acid in neurological disease: opportunities for novel drug discovery. Adv. Pharmacol. 30:85.
15. Saito, K., Nowak, T.S., Markey, S.P., and Heyes, M.P., 1993, Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:180.
16. Swartz, K.J., Matson, W.R., Mac Garvey, U., Ryan, E.A., and Beal, M.F., 1990, Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorimetric detection and coulometric electrode array detection. Anal. Biochem. 185:363.
17. Schwarcz, R., 1992, Excitotoxins, kynurenines and neuropsychiatric diseases: implications for drug development, in: "Drug Research Related to Neuroactive Amino Acids", A. Schousboe, N.H. Diemer, and H. Kofod, eds., Munksgaard, Copenhagen.
18. Schwarcz, R., Du, F., Schmidt, W., Turski, W.A., Gramsbergen, J.P.B., Okuno, E., and Roberts, R.C., 1992, Kynurenic acid: a potential pathogen in brain disorders, in: "Neurotoxins and Neurodegenerative Disease", J.W. Langston and A. Young eds., Ann. N.Y. Acad. Sci. Vol. 648, New York, p. 140.
19. Speciale, C., Okuno, E., and Schwarcz, R., 1987, Increased quinolinic acid metabolism following neuronal degeneration in the rat hippocampus. Brain Res. 436:18.
20. + independent transporter of neutral amino acids in astrocytes. J. Neurosci., 9:2066.
21. Speciale, C., Ungerstedt, U., and Schwarz, R., 1989b, Production of extracellular quinolinic acid in the striatum: studies by microdialysis in unanesthetized rats. Neurosci. Lett. 104:345.
22. Speciale, C., Wu, H.-Q., Gramsbergen, J.B., Turski, W.A., Ungerstedt, U., and Schwarcz, R., 1990, Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effects of aminooxyacetic acid. Neurosci. Lett. 116:198.
23. Stone, T.W., Neuropharmacology of quinolinic and kynurenic acids, 1993, Pharmacol. Rev. 45:309.
24. Wu, H.-Q, Baran, H., Ungerstedt, U., and Schwarcz, R., 1992, Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4: 1264.
25. Wu, H.-Q., and Schwarcz, R., 1994, Seizure-related increases in extracellular kynurenic acid levels in the rat hippocampus. Soc. Neurosci., Abstr. 20, 408.